Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
King Legacy, a wholly owned subsidiary of Pfizer

King Legacy, a wholly owned subsidiary of Pfizer Recalls

All product recalls associated with King Legacy, a wholly owned subsidiary of Pfizer.

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Apr 2013

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–3 of 3 recalls

Levoxyl 88mcg Tablets (Pfizer) – Subpotent Medication (2013)

Subpotent Drug: The products were below specification for potency at the expiry stability point.

Class IIModerate

FDAApr 30, 2013Nationwide• King Legacy, a wholly owned subsidiary of Pfizer

Levoxyl 175mcg Tablets (Pfizer) – Subpotent Medication (2013)

Subpotent Drug: The products were below specification for potency at the expiry stability point.

Class IIModerate

FDAApr 30, 2013Nationwide• King Legacy, a wholly owned subsidiary of Pfizer

Levoxyl 137mcg Tablets (Pfizer) – Subpotent Medication (2013)

Subpotent Drug: The products were below specification for potency at the expiry stability point.

Class IIModerate

FDAApr 30, 2013Nationwide• King Legacy, a wholly owned subsidiary of Pfizer